Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Conticello, US
Richard Conticello, Cortlandt Manor, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100029629 | ACYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY - The present disclosure provides compounds having affinity for the 5-HT | 02-04-2010 |
Richard Conticello, Cortland Manor, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100016297 | ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY - The present disclosure provides compounds having affinity for the 5-HT | 01-21-2010 |
Richard Conticello, Ossining, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090221661 | PHOSPHODIESTERASE 4 INHIBITORS - Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs. | 09-03-2009 |
Richard D. Conticello, Cortlandt Manor, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090099175 | Phosphodiesterase 10 inhibitors - The present invention if directed to certain cinnoline compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and processes for preparing such compounds. The invention is also directed to methods of treating diseases mediated by PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like. | 04-16-2009 |
Richard D. Conticello, Ossining, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080207660 | PHOSPHODIESTERASE 4 INHIBITORS - Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs. | 08-28-2008 |
Richard Dennis Conticello, Ossining, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090306156 | PHOSPHODIESTERASE 4 INHIBITORS - Selective PDE4 inhibition is achieved by novel compounds, e.g., 4-(substituted-phenyl)-2-pyrrolidinone compounds. The compounds of the present invention are of formula I: | 12-10-2009 |
Thomas Conticello, St. James, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090247299 | Systems and Methods for Controlling Navigation on a Wearable Device - A system includes a mobile unit (“MU”) including a display; and a peripheral device, in communication with the MU, transmitting a directional input signal to the MU. The MU adjusts the display based on the directional input signal. | 10-01-2009 |
Vincent P. Conticello, Decatur, GA US
| Patent application number | Description | Published |
|---|---|---|
| 20100048473 | Modified Protein Polymers - In an embodiment, a number of synthetic protein triblock copolymers are provided comprising first and second end hydrophobic blocks separated by a central hydrophilic block. In particular, the synthetic proteins are elastin-mimetic proteins having improved mechanical characteristics and related methods of making the proteins with the capability of providing precise control over the mechanical properties. Provided are proteins used in a number of medical devices such as artificial blood vessels, shunts, stents or as embolic agents in situations where it is desired to stop or reduce blood flow or pressure in a localized region. | 02-25-2010 |